Back to search
FDAFDA · Food and drugs·Recall number D-0045-2025

Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61.

Published November 20, 2024 · Recall initiated: November 5, 2024

Summary

FDA records drug Class III recall D-0045-2025, published November 20, 2024 and initiated November 5, 2024. Recalling firm: The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories; Status: Terminated; Reported quantity: 25814 tablets; Lot: Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Distributor
Nationwide in the US.
Lot
Lot#: T04888, Exp 11/2024; T04946, Exp 12/2024; T04970, Exp 07/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USA, NDC 0904-6441-61. recalled?

Yes. FDA published recall D-0045-2025 on November 20, 2024. Reported hazard: Failed Impurities/Degradation Specifications; during routine stability testing for impurities.

What should I do if I have this product?

Voluntary: Firm initiated · Letter